# Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients

> **NCT05117450** · NA · RECRUITING · sponsor: **CHU de Reims** · enrollment: 302 (estimated)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DEVICE:** Decrease per-dialytic heparin therapy

## Key facts

- **NCT ID:** NCT05117450
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-17
- **Primary completion:** 2026-11-17
- **Final completion:** 2026-12-17
- **Target enrollment:** 302 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05117450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05117450, "Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05117450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*